Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2272 | 4638 | 32.1 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
2272 | 2 | HEPARIN INDUCED THROMBOCYTOPENIA//ARGATROBAN//HIRUDIN | 4638 |
2034 | 1 | HEPARIN INDUCED THROMBOCYTOPENIA//ARGATROBAN//LEPIRUDIN | 2380 |
2400 | 1 | THROMBIN INHIBITOR//HIRUDIN//XIMELAGATRAN | 2258 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEPARIN INDUCED THROMBOCYTOPENIA | authKW | 3582733 | 13% | 87% | 623 |
2 | ARGATROBAN | authKW | 1220991 | 6% | 72% | 257 |
3 | HIRUDIN | authKW | 729933 | 5% | 48% | 231 |
4 | THROMBIN INHIBITOR | authKW | 592857 | 4% | 46% | 195 |
5 | LEPIRUDIN | authKW | 476321 | 2% | 82% | 88 |
6 | DIRECT THROMBIN INHIBITORS | authKW | 390176 | 3% | 42% | 142 |
7 | DANAPAROID | authKW | 354374 | 2% | 77% | 70 |
8 | HIT | authKW | 349147 | 2% | 54% | 98 |
9 | HEPARIN | authKW | 335756 | 13% | 9% | 590 |
10 | MELAGATRAN | authKW | 281469 | 1% | 70% | 61 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 48024 | 31% | 1% | 1448 |
2 | Peripheral Vascular Diseases | 29389 | 24% | 0% | 1098 |
3 | Chemistry, Medicinal | 9327 | 14% | 0% | 641 |
4 | Cardiac & Cardiovascular System | 2585 | 10% | 0% | 483 |
5 | Pharmacology & Pharmacy | 1387 | 12% | 0% | 579 |
6 | Anesthesiology | 1207 | 3% | 0% | 157 |
7 | Chemistry, Organic | 925 | 8% | 0% | 370 |
8 | Respiratory System | 895 | 4% | 0% | 195 |
9 | Critical Care Medicine | 486 | 2% | 0% | 109 |
10 | Medicine, General & Internal | 439 | 6% | 0% | 288 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOL TRANSFUS MED | 77747 | 2% | 11% | 108 |
2 | MED COMBINATORIAL CHEM | 39810 | 0% | 55% | 11 |
3 | UNIT PHARMACOL HAEMOSTASEOL | 35535 | 0% | 60% | 9 |
4 | SERV HEMATOL HEMOSTASE | 35090 | 0% | 44% | 12 |
5 | ZENTRUM VASKULARE BIOL MED | 34632 | 0% | 53% | 10 |
6 | MICHAEL G DEGROOTE MED | 28225 | 1% | 10% | 43 |
7 | ZENTRUM INNOVAT KOMPETENZ HUMORALE IMMUNREAKT KAR | 26327 | 0% | 100% | 4 |
8 | PATHOL MOL MED | 20356 | 2% | 3% | 104 |
9 | CARDIOVASC THER EUT SECT | 19746 | 0% | 100% | 3 |
10 | NEW LEADS GENERAT | 19746 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | THROMBOSIS RESEARCH | 41260 | 5% | 2% | 254 |
2 | THROMBOSIS AND HAEMOSTASIS | 39414 | 5% | 2% | 245 |
3 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 38156 | 3% | 5% | 124 |
4 | CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS | 29739 | 2% | 5% | 86 |
5 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 23779 | 2% | 4% | 82 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 17228 | 6% | 1% | 259 |
7 | BLOOD COAGULATION & FIBRINOLYSIS | 15751 | 2% | 3% | 89 |
8 | HAEMOSTASIS | 15438 | 1% | 4% | 54 |
9 | PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS | 10457 | 1% | 7% | 24 |
10 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 5960 | 1% | 2% | 60 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPARIN INDUCED THROMBOCYTOPENIA | 3582733 | 13% | 87% | 623 | Search HEPARIN+INDUCED+THROMBOCYTOPENIA | Search HEPARIN+INDUCED+THROMBOCYTOPENIA |
2 | ARGATROBAN | 1220991 | 6% | 72% | 257 | Search ARGATROBAN | Search ARGATROBAN |
3 | HIRUDIN | 729933 | 5% | 48% | 231 | Search HIRUDIN | Search HIRUDIN |
4 | THROMBIN INHIBITOR | 592857 | 4% | 46% | 195 | Search THROMBIN+INHIBITOR | Search THROMBIN+INHIBITOR |
5 | LEPIRUDIN | 476321 | 2% | 82% | 88 | Search LEPIRUDIN | Search LEPIRUDIN |
6 | DIRECT THROMBIN INHIBITORS | 390176 | 3% | 42% | 142 | Search DIRECT+THROMBIN+INHIBITORS | Search DIRECT+THROMBIN+INHIBITORS |
7 | DANAPAROID | 354374 | 2% | 77% | 70 | Search DANAPAROID | Search DANAPAROID |
8 | HIT | 349147 | 2% | 54% | 98 | Search HIT | Search HIT |
9 | HEPARIN | 335756 | 13% | 9% | 590 | Search HEPARIN | Search HEPARIN |
10 | MELAGATRAN | 281469 | 1% | 70% | 61 | Search MELAGATRAN | Search MELAGATRAN |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WARKENTIN, TE , GREINACHER, A , KOSTER, A , LINCOFF, AM , (2008) TREATMENT AND PREVENTION OF HEPARIN-INDUCED THROMBOCYTOPENIA.CHEST. VOL. 133. ISSUE 6. P. 340S -380S | 181 | 89% | 308 |
2 | LINKINS, LA , DANS, AL , MOORES, LK , BONA, R , DAVIDSON, BL , SCHULMAN, S , CROWTHER, M , (2012) TREATMENT AND PREVENTION OF HEPARIN-INDUCED THROMBOCYTOPENIA ANTITHROMBOTIC THERAPY AND PREVENTION OF THROMBOSIS, 9TH ED: AMERICAN COLLEGE OF CHEST PHYSICIANS EVIDENCE-BASED CLINICAL PRACTICE GUIDELINES.CHEST. VOL. 141. ISSUE 2. P. E495S-E530S | 128 | 85% | 87 |
3 | PRECHEL, M , WALENGA, JM , (2012) HEPARIN-INDUCED THROMBOCYTOPENIA: AN UPDATE.SEMINARS IN THROMBOSIS AND HEMOSTASIS. VOL. 38. ISSUE 5. P. 483 -496 | 127 | 99% | 23 |
4 | MAGNANI, HN , GALLUS, A , (2006) HEPARIN-INDUCED THROMBOCYTOPENIA (HIT) - A REPORT OF 1,478 CLINICAL OUTCOMES OF PATIENTS TREATED WITH DANAPAROID (ORGARAN) FROM 1982 TO MID-2004.THROMBOSIS AND HAEMOSTASIS. VOL. 95. ISSUE 6. P. 967-981 | 141 | 93% | 57 |
5 | HAUPTMANN, J , STURZEBECHER, J , (1999) SYNTHETIC INHIBITORS OF THROMBIN AND FACTOR XA: FROM BENCH TO BEDSIDE.THROMBOSIS RESEARCH. VOL. 93. ISSUE 5. P. 203 -241 | 194 | 79% | 108 |
6 | SALTER, BS , WEINER, MM , TRINH, MA , HELLER, J , EVANS, AS , ADAMS, DH , FISCHER, GW , (2016) HEPARIN-INDUCED THROMBOCYTOPENIA A COMPREHENSIVE CLINICAL REVIEW.JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. VOL. 67. ISSUE 21. P. 2519 -2532 | 124 | 89% | 0 |
7 | WARKENTIN, TE , GREINACHER, A , (2004) HEPARIN-INDUCED THROMBOCYTOPENIA: RECOGNITION, TREATMENT, AND PREVENTION.CHEST. VOL. 126. ISSUE 3. P. 311S-337S | 114 | 88% | 314 |
8 | DAGER, WE , DOUGHERTY, JA , NGUYEN, PH , MILITELLO, MA , SMYTHE, MA , (2007) HEPARIN-INDUCED THROMBOCYTOPENIA: TREATMENT OPTIONS AND SPECIAL CONSIDERATIONS.PHARMACOTHERAPY. VOL. 27. ISSUE 4. P. 564-587 | 141 | 87% | 22 |
9 | CUKER, A , (2011) HEPARIN-INDUCED THROMBOCYTOPENIA: PRESENT AND FUTURE.JOURNAL OF THROMBOSIS AND THROMBOLYSIS. VOL. 31. ISSUE 3. P. 353-366 | 110 | 96% | 17 |
10 | NICOLAIDES, A , FAREED, J , KAKKAR, AK , COMEROTA, AJ , GOLDHABER, SZ , HULL, R , MYERS, K , SAMAMA, M , FLETCHER, J , KALODIKI, E , ET AL (2013) HEPARIN-INDUCED THROMBOCYTOPENIA.CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. VOL. 19. ISSUE 2. P. 208-214 | 101 | 99% | 3 |
Classes with closest relation at Level 2 |